← Back to legislation

Safe Step Act

U.S. Congress · S2903 · In Committee

What the bill says

S2903 · U.S. Congress · In Committee

Introduced 2025-09-18. Latest action: Committee on Health, Education, Labor, and Pensions. Hearings held.

View on Congress.gov →

Sponsors

Text versions

  • Introduced in Senate — 2025-09-18 — XML

What analysts say

No nonpartisan analysis on file for this measure yet.

What politicians say

No linked claims or utterances yet — no one on record has cited this measure to justify a public argument.

Action History

DateAction
2026-03-19Committee on Health, Education, Labor, and Pensions. Hearings held.
2025-09-18Introduced in Senate
2025-09-18Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Lobbying on this bill

Showing 25 of 58 bill mentions.

Honesty note: each filer below disclosed lobbying on this bill — that much the filing tells us. But the dollar figure is their total lobbying spend for the whole quarter across all their issues, not the amount spent on this bill, and the filing never says whether they supported or opposed it.

Registrant (lobbying firm)ClientPeriodReported quarterly amountExtraction
CROHN'S & COLITIS FOUNDATION CROHN'S & COLITIS FOUNDATION Q2 2026 $40,000 Probable
OTSUKA AMERICA PHARMACEUTICAL, INC. OTSUKA AMERICA PHARMACEUTICAL, INC. Q2 2026 $1,240,000 Explicit
LUNDBECK LLC LUNDBECK LLC Q2 2026 $180,000 Explicit
AMERICAN COLLEGE OF SURGEONS AMERICAN COLLEGE OF SURGEONS Q2 2026 $240,000 Explicit
AMERICAN COLLEGE OF SURGEONS AMERICAN COLLEGE OF SURGEONS Q2 2026 $240,000 Explicit
AMERICAN COLLEGE OF SURGEONS PROFESSIONAL ASSOCIATION AMERICAN COLLEGE OF SURGEONS PROFESSIONAL ASSOCIATION Q2 2026 $30,000 Explicit
AMERICAN COLLEGE OF SURGEONS PROFESSIONAL ASSOCIATION AMERICAN COLLEGE OF SURGEONS PROFESSIONAL ASSOCIATION Q2 2026 $30,000 Explicit
ASSOCIATION FOR CLINICAL ONCOLOGY ASSOCIATION FOR CLINICAL ONCOLOGY Q2 2026 $480,000 Explicit
AMERICAN ACADEMY OF OTOLARYNGOLOGY-HEAD AND NECK SURGERY AMERICAN ACADEMY OF OTOLARYNGOLOGY-HEAD AND NECK SURGERY Q2 2026 $286,331 Explicit
AMERICAN ACADEMY OF OTOLARYNGOLOGY-HEAD AND NECK SURGERY AMERICAN ACADEMY OF OTOLARYNGOLOGY-HEAD AND NECK SURGERY Q2 2026 $286,331 Explicit
AMERICAN ACADEMY OF OTOLARYNGOLOGY-HEAD AND NECK SURGERY AMERICAN ACADEMY OF OTOLARYNGOLOGY-HEAD AND NECK SURGERY Q2 2026 $286,331 Explicit
EVERYLIFE FOUNDATION FOR RARE DISEASES EVERYLIFE FOUNDATION FOR RARE DISEASES Q2 2026 $40,000 Explicit
CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. HEMATOLOGY ONCOLOGY PHARMACY ASSOCIATION Q2 2026 $50,000 Explicit
AMERICAN ACADEMY OF NEUROLOGY AMERICAN ACADEMY OF NEUROLOGY Q2 2026 $460,000 Explicit
AMERICAN ACADEMY OF NEUROLOGY AMERICAN ACADEMY OF NEUROLOGY Q2 2026 $460,000 Explicit
UCB, INC. UCB, INC. Q2 2026 $710,000 Explicit
CONGRESS OF NEUROLOGICAL SURGEONS CONGRESS OF NEUROLOGICAL SURGEONS Q2 2026 $35,000 Explicit
AMERICAN ASSOCIATION OF NEUROLOGICAL SURGEONS AMERICAN ASSOCIATION OF NEUROLOGICAL SURGEONS Q2 2026 $35,000 Explicit
ALKERMES, INC. ALKERMES, INC. Q2 2026 $930,000 Explicit
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC. AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC Q2 2026 $1,240,000 Explicit
FAEGRE DRINKER BIDDLE & REATH LLP CROHN'S & COLITIS FOUNDATION Q2 2026 $20,000 Explicit
AMERICAN PSYCHIATRIC ASSOCIATION AMERICAN PSYCHIATRIC ASSOCIATION Q2 2026 $137,391 Explicit
ASTRAZENECA PHARMACEUTICALS LP ASTRAZENECA PHARMACEUTICALS LP Q2 2026 $1,680,000 Probable
ASSOCIATION OF CANCER CARE CENTERS (FKA ASSOCIATION OF COMMUNITY CANCER CENTERS) ASSOCIATION OF CANCER CARE CENTERS (FKA ASSOCIATION OF COMMUNITY CANCER CENTERS) Q2 2026 $10,000 Explicit
EPILEPSY FOUNDATION EPILEPSY FOUNDATION Q2 2026 $150,000 Explicit

Source: Senate LDA filings.